Capital Research Global Investors Vericel Corp Transaction History
Capital Research Global Investors
- $440 Billion
- Q1 2025
A detailed history of Capital Research Global Investors transactions in Vericel Corp stock. As of the latest transaction made, Capital Research Global Investors holds 654,461 shares of VCEL stock, worth $27.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
654,461Holding current value
$27.2 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VCEL
# of Institutions
291Shares Held
52.1MCall Options Held
36.7KPut Options Held
6.4K-
Black Rock Inc. New York, NY8.06MShares$334 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$145 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.88MShares$120 Million3.98% of portfolio
-
State Street Corp Boston, MA2.44MShares$101 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.27MShares$94.4 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.96B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...